As the global epidemic is being contained and ꦕChina’s economic growth has returned to normal, the growth of the country's healthcare sector is likel♎y to gradually slow down to pre-pandemic levels. In the second quarter of 2021, the ...

In🗹dia’s pharmaceuticals and healthcare sector has been dominated by a second wave of COVID-19 infections beওginning in April 2021 driven by the Delta variant. The surge caught the Indian government and the pharmaceuticals and ...

China's healthcare system is hospital-centric, and most of the inpatient and outpatient care in t🎶he country is delivered in public hospitals and basic medical institutions. However, due to the growing demand ...

Since China initiated 5G technology R&D and 🅷standard formulation in 2013, the landmark national-level policy has been Made in China 2025 issued by the State Council in 2015. 5G technology, along with integrated circuits ...

Chℱina’s successful recovery from the COVওID-19 outbreak back in mid-2020 had a positive effect on its economic performance as well as on separate sectors, including healthcare. China’s GDP managed to return to a usual pre-pandemic ...

India is a world leader in the production and export of generic pharmaceuticals, acco🍌unting for approximately 20% of the global volume of generic drug sales. Despite its export markets success, India’s pharmaceuticals and ꦬ;healthcare ...

The Philippines pharmac𒁃euticals and healthcare sector is entering a phase of accelerated growth. The Philippines economy has grown considerably over the recent years, creating a growing middle-class population with the means to access ...

The SEA region has had an admirable record in improving its record against infectious diseases over the nearly three decades from 1990 to 2019. The region’s rapid economic growth rel🎐ative to the rest of the world h♏as contributed to ...

Indonesiaꦚ’s pharmaceuticals and healthcare sector is one of the fastest-growing in the ASEAN region. The Indonesian go🍒vernment has prioritised widening healthcare access and increasing the healthcare system’s capacity since 2014. However, ...

Malaysia has one of the ASEAN region’s most developed pharmaceuticals and healthcare sectors. Malaysia has a two-tiered system in which the go🃏vernment, under the Ministry of Health, operates healthcare facilities and regulates medical practice ...